Olutasidenib Shows Promising Results for Myelodysplastic Syndrome Patients
A recent clinical study has revealed that the targeted drug olutasidenib demonstrates significant effectiveness in patients diagnosed with myelodysplastic syndrome (MDS), a blood disorder that is traditionally considered incurable without…